Increased Hazard of Myocardial Infarction With Insulin‐Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial

BACKGROUND: In the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial, randomization of diabetic patients with stable ischemic heart disease to insulin provision (IP) therapy, as opposed to insulin sensitization (IS) therapy, resulted in biochemical evidence of impaired fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Asrar A., Chung, Matthew J., Novak, Eric, Brown, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634262/
https://www.ncbi.nlm.nih.gov/pubmed/28903941
http://dx.doi.org/10.1161/JAHA.117.005946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634262/
https://www.ncbi.nlm.nih.gov/pubmed/28903941
http://dx.doi.org/10.1161/JAHA.117.005946

Ejemplares similares